Affinia Therapeutics, an innovative gene therapy company with a pipeline of rationally designed adeno-associated virus (AAV) gene therapies for devastating cardiovascular and neurological diseases,...
GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy platform for tissue-selective delivery, announced the appointment of J. Rodrigo Mora, M.D., Ph.D.,...
Health Network One announced the appointment of Heyward Donigan as Chief Executive Officer, effective January 1, 2025. Additionally, the company announced that the current...
Technip Energies and Shell Catalysts & Technologies have agreed to strengthen their relationship and will be moving towards global exclusivity for the delivery of...
